USAID Funding Cuts Halt HIV Vaccine Research in Nigeria — IHVN

Concerns Over Funding Cuts and Continued Research Efforts

The Institute of Human Virology, Nigeria (IHVN) has raised concerns about the impact of recent funding cuts from the United States Agency for International Development (USAID) on HIV research in the country. These cuts have reportedly slowed down critical research work, especially in the development of new treatments and vaccines for HIV. Despite these challenges, researchers remain committed to their mission, emphasizing that the pause in funding does not mean the end of their efforts.

At a press briefing held ahead of the IHVN’s 3rd Annual Scientific Symposium in Abuja, Prof. Alash’le Abimiku, Executive Director of the International Research Centre of Excellence (IRCE), shared insights into the current state of research. She explained that the IRCE had previously received USAID funding to develop HIV vaccines, but this support has now been discontinued. However, she stressed that the team is still actively working on sequencing the viruses circulating in Nigeria, even without the financial backing.

Prof. Abimiku highlighted that the team recently collaborated with researchers at the University of Cape Town in South Africa, focusing on understanding how the viruses in Nigeria differ from those in other regions like Kenya. “The viruses we are seeing here are different from those in South Africa or Kenya,” she noted. This ongoing work is essential for tailoring effective treatments and vaccines to the specific needs of the Nigerian population.

Despite the funding cut, the research team has not stopped its efforts. Prof. Abimiku emphasized that they are preparing for future opportunities when funding may be restored. “We want to be ready when they say, okay, here’s a plan to go and test it in people,” she said. The team continues to focus on local virus strains, ensuring that their research remains relevant and impactful.

In addition to HIV vaccine research, the team is also exploring potential solutions for Lassa fever. Prof. Abimiku revealed that they are collaborating with two groups to test the effectiveness of Lassa vaccines. “We’re very excited because many viruses are problematic in this region, and we’re working to identify a vaccine that can effectively combat Lassa,” she said.

Policy Engagement and Public Health Impact

The IHVN CEO, Dr. Patrick Dakum, emphasized the institute’s role in informing public health policy through research. He stated that the institute focuses on virus threats, particularly during outbreaks and pandemics. “We look at the patterns of microorganisms, virus systems, and cells to understand how they change and what risks they pose,” he explained.

Dakum also highlighted the importance of collaboration with government stakeholders. “We consult with the government from the beginning of any research project,” he said. “Involving policymakers ensures that our findings can be translated into actionable strategies.”

One example of this collaboration was the research that led to the decentralization of HIV services from secondary institutions to community levels. “Our research showed that patients receive the same quality of care at the primary level using non-physician healthcare workers,” Dakum said.

Community involvement is another key aspect of the institute’s work. Dr. Dakum mentioned the use of community advisory boards and ethical clearance processes to ensure that research aligns with local values and regulations. “Ethical clearance is crucial, and it involves the National Health Research Ethics Committee,” he added.

Advocacy for Research Funding and Integrity

The IHVN Chief Operating Officer, Dr. Charles Olalekan Mensah, reiterated the institute’s commitment to advocating for increased funding for scientific research. Despite challenges, he expressed hope that funding would improve in the future. “We are not giving up on the government. We continue to engage and hope that scientific research will receive more attention,” he said.

Mensah also spoke about the institute’s efforts to promote research integrity in Nigeria. “We are supporting the country in establishing a national framework for research integrity,” he said. Recently, the institute hosted a conference on this topic, bringing together local and international institutions to discuss best practices.

The COO emphasized the importance of communication and collaboration in research. “Good research requires scrutiny and validation by others,” he said. “International standards are essential, especially when working with global partners.”

Conclusion

Despite funding challenges, the IHVN remains dedicated to advancing public health through research. The institute continues to collaborate with government agencies, communities, and international partners to address virus-related threats and improve health outcomes. As the research landscape evolves, the focus remains on innovation, integrity, and the long-term impact of scientific discovery.